Trial Profile
An open-label, prospective, crossover, randomised, comparative pharmacokinetic bioequivalence study of two tiotropium bromide formulations in healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 29 Sep 2016
Price :
$35
*
At a glance
- Drugs Tiotropium bromide (Primary)
- Indications Asthma; Chronic obstructive pulmonary disease
- Focus Pharmacokinetics
- 29 Sep 2016 New trial record